AREXVY

AREXVY is a medicine authorised by Swissmedic under authorisation number 69310. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 May 2024 and the authorisation is limited until 01 May 2029. ATC code J07BX05 places the medicine in the group Vaccines.

  • Dispensing category B
  • Authorisation number 69310
  • ATC J07BX05
  • Vaccines
Authorisation data
Authorisation number69310
NameAREXVY
Full nameAREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension
Authorisation holderGlaxoSmithKline AG
Medicinal product codeVaccines
Dispensing categoryB · Prescription only
ATC codeJ07BX05
First authorisation02 May 2024
Authorisation validity01 May 2029
Strengths
No.NameDispensing categoryAuthorisation date
1AREXVY, Pulver und Suspension zur Herstellung einer InjektionssuspensionB02 May 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)J07BX0508.08.B
310Durchstechflasche(n)J07BX0508.08.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is AREXVY authorised in Switzerland?

Yes. AREXVY is authorised by Swissmedic under authorisation number 69310, data as of 01 September 2026. The authorisation is limited until 01 May 2029.

Which dispensing category does AREXVY have?

AREXVY is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of AREXVY?

The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com